Multiple Myeloma: Diagnosis and Treatment

Mayo Clinic Proceedings
S Vincent Rajkumar, Shaji Kumar

Abstract

The diagnosis and treatment of multiple myeloma has changed dramatically in the past decade. The disease definition has been updated to include highly specific biomarkers in addition to established markers of end-organ damage. The staging system has been revised to combine both measures of tumor burden and disease biology. Advances in therapy have resulted in a marked improvement in overall survival. New drugs introduced in the past few years include carfilzomib, pomalidomide, panobinostat, ixazomib, elotuzumab, and daratumumab. In this review, we outline the current approach to the diagnosis, prognosis, and management of multiple myeloma.

References

Jun 1, 1996·The American Journal of Medicine·M M OkenJ M Bennett
Oct 19, 2001·Oncogene·P L Bergsagel, W M Kuehl
Feb 22, 2002·The New England Journal of Medicine·Robert A KyleL Joseph Melton
May 7, 2002·Nature Reviews. Cancer·W Michael Kuehl, P Leif Bergsagel
Aug 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James R BerensonUNKNOWN American Society of Clinical Oncology Bisphosphonates Expert Panel
Jan 17, 2003·Mayo Clinic Proceedings·Robert A KylePhilip R Greipp
Jan 28, 2003·Journal of Neurosurgery·Daryl R FourneyZiya L Gokaslan
May 7, 2003·The Lancet Oncology·Ambuj KumarBenjamin Djulbegovic
May 9, 2003·The New England Journal of Medicine·J Anthony ChildUNKNOWN Medical Research Council Adult Leukaemia Working Party
Jun 27, 2003·The New England Journal of Medicine·Paul G RichardsonKenneth C Anderson
Aug 2, 2003·Blood·Joan Bladé Gertz Morie
Sep 11, 2003·The Lancet Oncology·Sonja SeidlJohannes Drach
Dec 26, 2003·The New England Journal of Medicine·Michel AttalUNKNOWN InterGroupe Francophone du Myélome
Apr 6, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip R GreippJan Westin
Jun 7, 2005·Proceedings of the National Academy of Sciences of the United States of America·Teru HideshimaKenneth C Anderson
Dec 21, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S Vincent RajkumarUNKNOWN Eastern Cooperative Oncology Group
Mar 31, 2006·The New England Journal of Medicine·Robert A KyleL Joseph Melton
Jun 30, 2006·The New England Journal of Medicine·Ruth Collins-Nakai
Jul 29, 2006·Blood·Michel AttalUNKNOWN Inter-Groupe Francophone du Myélome (IFM)
Mar 16, 2007·The New England Journal of Medicine·Benedetto BrunoMario Boccadoro
May 9, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michele CavoMichele Baccarani
Jun 22, 2007·The New England Journal of Medicine·Robert A KyleS Vincent Rajkumar
Jun 27, 2007·British Journal of Haematology·Bart BarlogieJohn D Shaughnessy
Aug 8, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert Z OrlowskiJean-Luc Harousseau
Nov 23, 2007·The New England Journal of Medicine·Donna M WeberUNKNOWN Multiple Myeloma (009) Study Investigators
Mar 26, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S Vincent RajkumarJoan Bladé
Aug 30, 2008·The New England Journal of Medicine·Jesús F San MiguelUNKNOWN VISTA Trial Investigators
Nov 29, 2008·Leukemia·G D Roodman
Mar 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew SpencerNola Kennedy
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cyrille HulinPhilippe Moreau
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martha Q LacyS Vincent Rajkumar
Sep 30, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul G RichardsonKenneth C Anderson
Feb 24, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jens HillengassHartmut Goldschmidt

❮ Previous
Next ❯

Citations

Feb 29, 2016·Current Hematologic Malignancy Reports·Vijay Ramakrishnan, Anita D'Souza
Jul 19, 2016·Clinical Lymphoma, Myeloma & Leukemia·Victor H Jimenez-ZepedaNizar J Bahlis
Jul 15, 2016·Lancet·Philippe Moreau, S Vincent Rajkumar
Aug 25, 2016·The New England Journal of Medicine·Antonio PalumboUNKNOWN CASTOR Investigators
Oct 23, 2016·International Journal of Cancer. Journal International Du Cancer·Chirawadee SathitruangsakSabine Mai
Oct 16, 2016·Blood·S Vincent Rajkumar, Jean Luc Harousseau
Jan 12, 2017·Expert Review of Hematology·Jacob P LaubachPaul G Richardson
Jan 23, 2017·International Journal for Parasitology. Drugs and Drug Resistance·Neil H BagnallAndrew C Kotze
Oct 21, 2016·The American Journal of Dermatopathology·Neslihan AkdoğanDevrim Tuba Ünal
Mar 24, 2018·Cancer Cell International·Dehui XuMichael G Kong
Mar 9, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Christopher KimPaul C Cheng
Jun 23, 2018·Expert Review of Anticancer Therapy·Paul G RichardsonPeter O'Gorman
Feb 6, 2018·Journal of Investigative Medicine High Impact Case Reports·Anum BilalGulvahid Shaikh
Jul 31, 2018·Future Oncology·Susanne Strifler, Stefan Knop
Aug 7, 2018·British Journal of Haematology·Angelica MacaudaDaniele Campa
Aug 22, 2018·Hematological Oncology·Leo SekineRodrigo Antonini Ribeiro
Sep 13, 2018·Journal of Postgraduate Medicine·S M ThambiR Benson
Mar 20, 2018·Journal of Medical Case Reports·Douglas A SalgueroWillaim Sierraalta
Apr 6, 2019·Leukemia & Lymphoma·Bing ZhaiRenxi Wang
May 3, 2019·Journal of Investigative Medicine High Impact Case Reports·Jordana Cheta, Michael Binder
May 18, 2019·American Society of Clinical Oncology Educational Book·Barry PaulSaad Z Usmani
Jul 19, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Yoo-Rin Cho, Yang-Sook Yoo
Apr 11, 2018·The Journal of Pharmacology and Experimental Therapeutics·Vidya Ramakrishnan, Donald E Mager
Aug 6, 2019·British Journal of Haematology·Howard R TerebeloUNKNOWN CONNECT MM Registry Investigators
Nov 13, 2019·Cancer Medicine·Andrew T StefkaAndrzej J Jakubowiak
Nov 30, 2019·Cells·Thomas G MartinKenneth C Anderson
Jan 24, 2020·British Journal of Nursing : BJN·Clare Horgan CuffeCatherine McCabe
Jan 26, 2020·International Journal of Molecular Sciences·Karolina ŁuczkowskaBogusław Machaliński

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Clinical Oncology
Joelle El-Amm, Imad A Tabbara
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
Emily Ashjian, Kimberly Redic
© 2022 Meta ULC. All rights reserved